Get the Stockscreener App
3.88
0.64%
-0.04
Annovis Bio Inc Stock (ANVS) Forecast
The Annovis Bio Inc (ANVS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.7496, representing a +22.41% increase from the current price of $3.88. The highest analyst price target is $5.5875, and the lowest is $3.9117.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ANVS Price Target
Average 7.8003
(+101.04% Upside)
Is Annovis Bio Inc (ANVS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 53.30 | Neutral |
| STOCH(9,6) | 74.34 | Neutral |
| STOCHRSI(14) | 63.15 | Neutral |
| MACD(12,26) | 0.0505 | Buy |
| ADX(14) | 16.75 | Neutral |
| William %R | -29.55 | Neutral |
| CCI(14) | 46.16 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.719
Buy
|
3.8111
Buy
|
| MA20 |
3.7465
Buy
|
3.7897
Buy
|
| MA50 |
3.4904
Buy
|
3.5117
Buy
|
| MA100 |
2.848
Buy
|
3.1633
Buy
|
| MA200 |
2.5235
Buy
|
3.385
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, ANVS could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 0 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on ANVS, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 53.3 indicates that ANVS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 74.34 indicates that ANVS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 63.15 indicates that ANVS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.75 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 46.16 indicates that ANVS is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ANVS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Annovis Bio Inc financial reports and earnings history, Annovis Bio Inc (ANVS) stock could reach $8.6263 by 2030, $28.51 by 2040 and $71.05 by 2050. See the projected annual prices until 2050 of the Annovis Bio Inc stock below:
- Annovis Bio Inc (ANVS) is expected to reach an average price of $29.47 in 2035, with a high prediction of $31.54 and a low estimate of $29.58. This indicates an $659.52% rise from the last recorded price of $3.88.
- Annovis Bio Inc (ANVS) stock is projected to chart a bullish course in 2040, with an average price target of $25.46, representing an $556.09% surge from its current level. The forecast ranges from a conservative $27.87 to a sky-high $28.51.
- Our analysts predict Annovis Bio Inc (ANVS) to jump 1,001% by 2045, soaring from $46.69 to an average price of $42.72, potentially reaching $49.82. While $46.69 is the low estimate, the potential upside is significant.
- Annovis Bio Inc (ANVS) stock is expected to climb by 2050, reaching an average of $71.81, a $1,751% jump from its current level. However, a wide range of estimates exists, with high and low targets of $71.05 and $71.42, respectively, highlighting the market's uncertainty.
Annovis Bio Inc Stock (ANVS) Year by Year Forecast
Annovis Bio Inc Stock (ANVS) Price Forecast for 2026
The predicted value for Annovis Bio Inc (ANVS) in 2026 is set at an average of $7.8003. Estimates vary from a peak of $15.41 to a trough of $0.1913, indicating an +101.04% surge from the present price of $3.88.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2026 | $4.1217 | $3.9117 | $5.5875 | +6.23% |
| March, 2026 | $3.134 | $2.504 | $4.8798 | -19.23% |
| April, 2026 | $0.1056 | $0.3656 | $3.892 | -97.28% |
| May, 2026 | $1.3233 | $0.2795 | $1.4324 | -65.89% |
| June, 2026 | $1.0689 | $0.7011 | $2.115 | -72.45% |
| July, 2026 | $11.62 | $0.657 | $15.41 | +199.47% |
| August, 2026 | $3.1016 | $2.1916 | $12.67 | -20.06% |
| September, 2026 | $3.4719 | $2.883 | $5.2596 | -10.52% |
| October, 2026 | $2.8942 | $1.7001 | $3.55 | -25.41% |
| November, 2026 | $5.7065 | $2.7723 | $7.1323 | +47.07% |
| December, 2026 | $4.17 | $0.1913 | $14.28 | +7.47% |
Annovis Bio Inc Stock (ANVS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Annovis Bio Inc (ANVS) is $5.9447, with a high forecast of $11.87 and a low forecast of $0.0206. This indicates an +53.21% increase from the last price of $3.88.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.4016 | $0.4037 | $8.7744 | -38.10% |
| February, 2027 | $0.2632 | $0.1653 | $1.9337 | -93.22% |
| March, 2027 | $0.8426 | $0.9911 | $0.9047 | -78.28% |
| April, 2027 | $0.6058 | $0.0737 | $1.7737 | -84.39% |
| May, 2027 | $0.0158 | $0.0779 | $1.5179 | -99.59% |
| June, 2027 | $0.1653 | $0.2262 | $1.1963 | -95.74% |
| July, 2027 | $1.7569 | $0.2411 | $0.227 | -54.72% |
| August, 2027 | $4.0884 | $2.4948 | $2.5534 | +5.37% |
| September, 2027 | $5.6379 | $4.1942 | $4.938 | +45.31% |
| October, 2027 | $2.5395 | $3.0195 | $5.1458 | -34.55% |
| November, 2027 | $8.0789 | $0.2232 | $11.87 | +108.22% |
| December, 2027 | $0.9394 | $0.0206 | $9.161 | -75.79% |
Annovis Bio Inc Stock (ANVS) Price Forecast for 2028
In 2028, Annovis Bio Inc (ANVS) is projected to reach an average price of $5.7334, with a high projection of $11.42 and a low estimate of $0.0458. This indicates an +47.77% rise from the last price of $3.88.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.2379 | $0.0458 | $1.8358 | -93.87% |
| February, 2028 | $0.2037 | $0.5337 | $0.35 | -94.75% |
| March, 2028 | $1.2768 | $0.0768 | $4.0684 | -67.09% |
| April, 2028 | $9.31 | $1.4189 | $11.42 | +139.95% |
| May, 2028 | $4.8493 | $5.4416 | $6.5254 | +24.98% |
| June, 2028 | $5.2447 | $5.067 | $4.3909 | +35.17% |
| July, 2028 | $5.5402 | $5.8586 | $5.6363 | +42.79% |
| August, 2028 | $4.3995 | $4.3856 | $3.4756 | +13.39% |
| September, 2028 | $3.7749 | $4.165 | $4.2011 | -2.71% |
| October, 2028 | $4.4204 | $4.5304 | $3.6304 | +13.93% |
| November, 2028 | $6.4497 | $4.4281 | $5.2397 | +66.23% |
| December, 2028 | $7.2151 | $6.9435 | $6.5363 | +85.96% |
Annovis Bio Inc Stock (ANVS) Price Forecast for 2029
The 2029 price forecast for Annovis Bio Inc Stock (ANVS) is $7.1116 on average, with a high prediction of $13.94 and a low estimate of $0.2832. This represents an +83.29% increase from the previous price of $3.88.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $9.0444 | $8.109 | $8.9244 | +133.10% |
| February, 2029 | $4.2899 | $6.1499 | $8.1982 | +10.56% |
| March, 2029 | $1.7753 | $0.2832 | $8.3286 | -54.24% |
| April, 2029 | $2.4307 | $2.2092 | $1.4807 | -37.35% |
| May, 2029 | $4.33 | $3.2223 | $2.85 | +11.60% |
| June, 2029 | $0.9455 | $3.3555 | $3.1839 | -75.63% |
| July, 2029 | $1.6509 | $0.9861 | $0.4878 | -57.45% |
| August, 2029 | $10.02 | $1.4748 | $13.94 | +158.24% |
| September, 2029 | $9.8191 | $10.48 | $11.53 | +153.07% |
| October, 2029 | $10.52 | $9.9688 | $9.6983 | +171.09% |
| November, 2029 | $9.7176 | $10.58 | $10.37 | +150.45% |
| December, 2029 | $8.9269 | $8.947 | $8.037 | +130.07% |
Annovis Bio Inc Stock (ANVS) Price Forecast for 2030
Annovis Bio Inc Stock (ANVS) is expected to reach an average price of $11.45 in 2030, with a high forecast of $19.08 and a low forecast of $3.8236. This signifies an +195.15% surge from the last price of $3.88.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $8.546 | $8.5563 | $8.6263 | +120.26% |
| February, 2030 | $8.7053 | $8.7855 | $8.2353 | +124.36% |
| March, 2030 | $10.53 | $8.6151 | $9.3246 | +171.51% |
| April, 2030 | $11.16 | $10.99 | $10.53 | +187.73% |
| May, 2030 | $12.82 | $12.02 | $12.70 | +230.49% |
| June, 2030 | $7.9323 | $9.7923 | $11.94 | +104.44% |
| July, 2030 | $4.5214 | $3.8236 | $7.1421 | +16.53% |
| August, 2030 | $6.6207 | $6.3613 | $5.0407 | +70.64% |
| September, 2030 | $7.5301 | $6.4904 | $6.0501 | +94.07% |
| October, 2030 | $3.2492 | $4.2292 | $6.3499 | -16.26% |
| November, 2030 | $3.5415 | $3.9478 | $3.7315 | -8.72% |
| December, 2030 | $15.13 | $8.6681 | $19.08 | +289.84% |
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):